Physician profile
Daniel N Ead
NPI 1457302895
$3,786.67
in general payments reported to CMS, 2019-2025
25 companies · $249 in 2025
The $249 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $702 · 2020: $876 · 2021: $974 · 2022: $224 · 2023: $360 · 2024: $402 · 2025: $249.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,011.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,011.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rochester Medical Corporation | $839.51 | 2019-2021 | |
| Boston Scientific Corporation | $426.99 | 2020-2024 | Rezum Generator |
| Abbvie INC. | $332.74 | 2019-2025 | Botox |
| C. R. Bard, INC. & Subsidiaries | $332.65 | 2019-2023 | |
| Astellas Pharma US INC | $229.26 | 2019-2021 | |
| Tolmar Pharmaceuticals, INC. | $206.46 | 2019-2022 | |
| Teleflex LLC | $151.08 | 2021-2025 | Urolift, Barrigel |
| Pfizer INC. | $151.05 | 2019-2021 | |
| Procept Biorobotics Corporation | $150.16 | 2024-2025 | Aquabeam System |
| Zimmer Biomet Holdings, INC. | $123.75 | 2020 | |
| Amniox Medical, INC. | $121.50 | 2020 | |
| Olympus America INC. | $116.83 | 2024 | Soltive |
| Endo Pharmaceuticals INC. | $103.54 | 2019-2022 | |
| Tolmar, INC. | $87.03 | 2023-2025 | Jatenzo, Eligard |
| Allergan, INC. | $78.27 | 2019-2020 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $67.86 | 2021-2024 | |
| Axonics, INC. | $53.99 | 2022 | |
| Coloplast Corp | $44.44 | 2020 | |
| Endo USA, INC. | $33.84 | 2025 | Xiaflex |
| Blue Earth Diagnostics | $32.09 | 2024 | |
| Verity Pharmaceuticals INC. | $29.59 | 2024 | Trelstar |
| Astrazeneca Pharmaceuticals LP | $23.09 | 2024 | Lynparza |
| Acerus Pharmaceuticals Corporation | $19.12 | 2022 | |
| Becton, Dickinson and Company | $18.32 | 2024 | Bard Urinary Drainage Bag |
| Laborie Medical Technologies Corp. | $13.51 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Ead listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.